注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4)   

Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4)

     
  • 0 - Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4) APR11392
    Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4) APR11392
    The purity of Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4) is 98.3%, determined by SEC-HPLC.
  • 0 - Anti-GFRA4 Reference Antibody (U.Penn. patent anti-GFRA4) APR11392
    Immobilized hu-GFRA4-his at 2 µg/mL can bind U.Penn. patent anti-GFRA4, EC50= 2.554 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P56159
Reactivity Human
Clonality Monoclonal
Isotype IgG1
Calculated MW 51456 Da
Additional Information
Target/Specificity GFRA4
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name GFRA1
Synonyms GDNFRA, RETL1, TRNR1
Function Coreceptor for GDNF, a neurotrophic factor that enhances survival and morphological differentiation of dopaminergic neurons and increases their high-affinity dopamine uptake (PubMed:10829012, PubMed:31535977). GDNF-binding leads to autophosphorylation and activation of the RET receptor (PubMed:31535977).
Cellular Location Cell membrane {ECO:0000250|UniProtKB:Q62997}; Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:Q62997}. Golgi apparatus, trans-Golgi network {ECO:0000250|UniProtKB:Q62997}. Endosome {ECO:0000250|UniProtKB:Q62997}. Endosome, multivesicular body {ECO:0000250|UniProtKB:Q62997}. Note=Localizes mainly to the plasma membrane. In the presence of SORL1, shifts to vesicular structures, including trans-Golgi network, endosomes and multivesicular bodies {ECO:0000250|UniProtKB:Q62997}
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价